vTv Therapeutics
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $36,839 | $-24 | $0 |
Gross Profit | 36,838 | -2 | ||
EBITDA | -13,052 | 24,135 | -7,135 | -10,338 |
EBIT | -13,054 | 24,134 | -7,137 | -10,340 |
Net Income | -13,054 | 24,134 | -7,138 | -8,698 |
Net Change In Cash | 0 | 36,839 | -24 | 0 |
Free Cash Flow | -11,443 | 9,154 | -9,251 | -5,222 |
Cash | 86,643 | 98,086 | 88,932 | 98,504 |
Basic Shares | 12,409 | 8,423 | 8,423 | 8,055 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $1,017 | $9 | $2,018 |
Gross Profit | -16 | 1,017 | -90 | 2,018 |
EBITDA | -31,058 | -22,516 | -25,863 | -24,766 |
EBIT | -31,074 | -22,605 | -25,953 | -24,858 |
Net Income | -26,974 | -18,462 | -20,250 | -19,164 |
Net Change In Cash | 0 | 1,017 | 9 | 2,018 |
Cost of Revenue | -1,289 | |||
Free Cash Flow | -25,255 | -25,307 | -19,081 | -15,267 |
Cash | 88,932 | 36,746 | 9,446 | 12,126 |
Basic Shares | 8,423 | 5,771 | 2,084 | 1,919 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$1.05 |
2026-03-31 | $1.65 |
2025-12-31 | -$0.58 |
2025-09-30 | -$1.08 |